Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells-Reference-Cited by-同舟云学术

Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells

Published:2024-05-28 Issue:11 Volume:67 Page:9277-9301
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Hua-Yu¹,Nguyen Thu P.¹,Sternisha Alex C.²,Carroll Christopher L.¹,Cross Bethany¹,Morlock Lorraine¹,Williams Noelle S.¹,McBrayer Samuel²,Nijhawan Deepak¹³^ORCID,De Brabander Jef K.¹^ORCID

Affiliation:

1. Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States

2. Children’s Medical Center Research Institute and Department of Pediatrics, UT Southwestern, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States

3. Department of Internal Medicine, Division of Hematology/Oncology and Program in Molecular Medicine, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States

Funder

Welch Foundation

McKnight Foundation

University of Texas Southwestern Medical Center

Cancer and Prevention Research Institute of Texas

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00402

Reference50 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Surveillance, Epidemiology, and End Results Program; National Cancer Institute, 2023. https://seer.cancer.gov/statfacts/html/brain.html (accessed 11-05-2023).

4. Glioblastoma Treatments: An Account of Recent Industrial Developments

5. Identification of human brain tumour initiating cells